CERS Stock Analysis: Buy, Sell, or Hold?
CERS - Cerus Corp
$2.18
0.02 (1.16%)
▲
5d:
-29.15%
30d:
-31.17%
90d:
-20.04%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When CERS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CERS is down 29.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CERS is down 29.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CERS is currently trading at $2.17, which is considered oversold relative to its 30-day fair value range of $2.72 to $3.25.
Technical Outlook: Technically, CERS is in a strong uptrend. Immediate support is located at $2.06, while resistance sits at $3.22.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.67 (+117.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CERS is in a strong uptrend. Immediate support is located at $2.06, while resistance sits at $3.22.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.67 (+117.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.72 -
$3.25
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 117.1% below Wall St target ($4.67)
- WARNING: Recommendation downgraded due to -29.2% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$2.72 -
$3.25
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.06
Resistance Level
$3.22
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Wall Street Target
$4.67
(+117.1%)
Revenue Growth (YoY)
24.1%
Profit Margin
-4.4%
Share & Embed Analysis
Last updated: August 03, 2026 3:46 PM ET
Data refreshes hourly during market hours. Next update: 4:46 PM
Data refreshes hourly during market hours. Next update: 4:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CERS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Dennis Green
SELL
127544 shares
2026-03-12
Richard J Benjamin
SELL
101740 shares
2026-03-12
Vivek K Jayaraman
SELL
165200 shares
2026-03-12
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 51 HOLD |
